Most young people with noncompaction cardiomyopathy can do well on drug treatments

18th January 2016

Most young people with left ventricular noncompaction cardiomyopathy can have favourable improvements in their heart function with early diagnosis and treatment with heart failure drugs, says a new study.

This particular type of cardiomyopathy can be difficult to treat but researchers, hypothesising that heart failure medications could help, looked at how young people taking at least one of the medications were doing.

The study involved researchers from three centres in America: Indiana University School of Medicine, Le Bonheur Children’s Hospital in Memphis and Cincinnati Children's Hospital.

A total of 51 children and young people met the criteria. Three (6 %) were on just a beta-blocker, 15 (29 %) on an ACE inhibitor (or ARB), and 33 (65 %) were on both types of drug. When they were followed up two years later almost 9 in 10 had improvements in heart function, while the rest had no change.

For more details, see here